Literature DB >> 25288756

Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway.

Matthias Drosten1, Eleanor Y M Sum2, Carmen G Lechuga2, Lucía Simón-Carrasco2, Harrys K C Jacob2, Raquel García-Medina2, Sidong Huang3, Roderick L Beijersbergen3, Rene Bernards3, Mariano Barbacid1.   

Abstract

The Ras family of small GTPases constitutes a central node in the transmission of mitogenic stimuli to the cell cycle machinery. The ultimate receptor of these mitogenic signals is the retinoblastoma (Rb) family of pocket proteins, whose inactivation is a required step to license cell proliferation. However, little is known regarding the molecular events that connect Ras signaling with the cell cycle. Here, we provide genetic evidence to illustrate that the p53/p21 Cdk-interacting protein 1 (Cip1)/Rb axis is an essential component of the Ras signaling pathway. Indeed, knockdown of p53, p21Cip1, or Rb restores proliferative properties in cells arrested by ablation of the three Ras loci, H-, N- and K-Ras. Ras signaling selectively inactivates p53-mediated induction of p21Cip1 expression by inhibiting acetylation of specific lysine residues in the p53 DNA binding domain. Proliferation of cells lacking both Ras proteins and p53 can be prevented by reexpression of the human p53 ortholog, provided that it retains an active DNA binding domain and an intact lysine residue at position 164. These results unveil a previously unidentified role for p53 in preventing cell proliferation under unfavorable mitogenic conditions. Moreover, we provide evidence that cells lacking Ras and p53 proteins owe their proliferative properties to the unexpected retroactivation of the Raf/Mek/Erk cascade by a Ras-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25288756      PMCID: PMC4210339          DOI: 10.1073/pnas.1417549111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  RAS oncogenes: the first 30 years.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

Review 2.  shRNA libraries and their use in cancer genetics.

Authors:  René Bernards; Thijn R Brummelkamp; Roderick L Beijersbergen
Journal:  Nat Methods       Date:  2006-09       Impact factor: 28.547

3.  Acetylation is indispensable for p53 activation.

Authors:  Yi Tang; Wenhui Zhao; Yue Chen; Yingming Zhao; Wei Gu
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

4.  Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein.

Authors:  S Mittnacht; H Paterson; M F Olson; C J Marshall
Journal:  Curr Biol       Date:  1997-03-01       Impact factor: 10.834

5.  Ras signaling is essential for skin development.

Authors:  M Drosten; C G Lechuga; M Barbacid
Journal:  Oncogene       Date:  2013-07-08       Impact factor: 9.867

6.  Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein.

Authors:  D S Peeper; T M Upton; M H Ladha; E Neuman; J Zalvide; R Bernards; J A DeCaprio; M E Ewen
Journal:  Nature       Date:  1997-03-13       Impact factor: 49.962

7.  Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen.

Authors:  M T Sáenz Robles; H Symonds; J Chen; T Van Dyke
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

8.  Mek1/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia.

Authors:  Florence A Scholl; Phillip A Dumesic; Deborah I Barragan; Kazutoshi Harada; Vickram Bissonauth; Jean Charron; Paul A Khavari
Journal:  Dev Cell       Date:  2007-04       Impact factor: 12.270

9.  Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.

Authors:  Asako Sakaue-Sawano; Hiroshi Kurokawa; Toshifumi Morimura; Aki Hanyu; Hiroshi Hama; Hatsuki Osawa; Saori Kashiwagi; Kiyoko Fukami; Takaki Miyata; Hiroyuki Miyoshi; Takeshi Imamura; Masaharu Ogawa; Hisao Masai; Atsushi Miyawaki
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

10.  Activation of ternary complex factor Elk-1 by MAP kinases.

Authors:  R Janknecht; W H Ernst; V Pingoud; A Nordheim
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more
  38 in total

1.  PDCD5 regulates cell proliferation, cell cycle progression and apoptosis.

Authors:  Penghui Li; Hongxin Fei; Lihong Wang; Huiyu Xu; Haiyan Zhang; Lihong Zheng
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

2.  Ras and p53: An unsuspected liaison.

Authors:  Matthias Drosten; Mariano Barbacid
Journal:  Mol Cell Oncol       Date:  2015-01-23

Review 3.  The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.

Authors:  Lucía Simón-Carrasco; Gerardo Jiménez; Mariano Barbacid; Matthias Drosten
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

4.  Response to Anti-EGFR Therapy in Patients with BRAF non-V600-Mutant Metastatic Colorectal Cancer.

Authors:  Rona Yaeger; Daisuke Kotani; Sebastián Mondaca; Aparna R Parikh; Hideaki Bando; Emily E Van Seventer; Hiroya Taniguchi; HuiYong Zhao; Claire N Thant; Elisa de Stanchina; Neal Rosen; Ryan B Corcoran; Takayuki Yoshino; Zhan Yao; Hiromichi Ebi
Journal:  Clin Cancer Res       Date:  2019-09-12       Impact factor: 12.531

5.  Context-Dependent Effects of Amplified MAPK Signaling during Lung Adenocarcinoma Initiation and Progression.

Authors:  Michelle Cicchini; Elizabeth L Buza; Kyra M Sagal; A Andrea Gudiel; Amy C Durham; David M Feldser
Journal:  Cell Rep       Date:  2017-02-21       Impact factor: 9.423

6.  A bibenzyl from Dendrobium ellipsophyllum induces apoptosis in human lung cancer cells.

Authors:  Anirut Hlosrichok; Somruethai Sumkhemthong; Boonchoo Sritularak; Pithi Chanvorachote; Chatchai Chaotham
Journal:  J Nat Med       Date:  2018-02-27       Impact factor: 2.343

7.  Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties.

Authors:  Yijun Gao; Matthew T Chang; Daniel McKay; Na Na; Bing Zhou; Rona Yaeger; Neilawattie M Torres; Keven Muniz; Matthias Drosten; Mariano Barbacid; Giordano Caponigro; Darrin Stuart; Henrik Moebitz; David B Solit; Omar Abdel-Wahab; Barry S Taylor; Zhan Yao; Neal Rosen
Journal:  Cancer Discov       Date:  2018-02-26       Impact factor: 39.397

8.  Modulation of Gq-Rho Signaling by the ERK MAPK Pathway Controls Locomotion in Caenorhabditis elegans.

Authors:  Brantley Coleman; Irini Topalidou; Michael Ailion
Journal:  Genetics       Date:  2018-04-03       Impact factor: 4.562

9.  Growth hormone is permissive for neoplastic colon growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Cuiqi Zhou; Maria Victoria Recouvreux; Anat Ben-Shlomo; Takako Araki; Robert Barrett; Michael Workman; Kolja Wawrowsky; Vladimir A Ljubimov; Magdalena Uhart; Shlomo Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-25       Impact factor: 11.205

10.  BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition.

Authors:  Zhan Yao; Neilawattie M Torres; Anthony Tao; Yijun Gao; Lusong Luo; Qi Li; Elisa de Stanchina; Omar Abdel-Wahab; David B Solit; Poulikos I Poulikakos; Neal Rosen
Journal:  Cancer Cell       Date:  2015-09-03       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.